Additional Information

Description

Gamunex-C 10% is a sterile, preservative-free immune globulin (IgG) solution for intravenous (IV) and subcutaneous (SC) administration. It is composed of purified human immunoglobulin G, derived from pooled plasma. It is indicated for the treatment of primary immunodeficiency (PI), idiopathic thrombocytopenic purpura (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP).

In patients with primary immunodeficiency, Gamunex-C provides essential antibodies to prevent recurrent bacterial infections. Regular infusions help maintain adequate IgG levels, reducing susceptibility to respiratory and systemic infections. For idiopathic thrombocytopenic purpura, it increases platelet counts by modulating immune activity, preventing excessive platelet destruction in patients with chronic or acute forms of the disease.

For chronic inflammatory demyelinating polyneuropathy, Gamunex-C is used as an immunomodulatory therapy to reduce nerve inflammation, improve motor function, and slow disease progression. The subcutaneous route is only indicated for primary immunodeficiency, while intravenous administration is used for all approved indications.